Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-12-11

FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for Chantix (varenicline tartrate) from Pfizer. The action updates the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHANTIX (varenicline tartrate)

Snippet

SUPPL AP for CHANTIX (VARENICLINE TARTRATE)